Schedule 13D ownership disclosure

PELTHOS THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 171126204

Event date: 2025-07-01

Filing-level shares
4,927,868
Percent of class
49.9%
  • Ligand Pharmaceuticals IncorporatedReported CIK 0000886163

    Shares: 4,927,868 · Class: 49.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-093838
Form type
SCHEDULE 13D
Filer
LIGAND PHARMACEUTICALS INC
CIK
CIK 886163
Filed
Jul 03, 2025
Reporting period
Jul 01, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub